Anthony Fauci likely to retire by the end of Biden’s term

Anthony Fauci likely to retire by the end of Biden’s term


Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, responds to questions from Senator Rand Paul (R-KY) during a Senate Health, Education, Labor, and Pensions Committee hearing to examine the federal response to the coronavirus disease (COVID-19) and new emerging variants at Capitol Hill in Washington, D.C., U.S. January 11, 2022.

Greg Nash | Reuters

Dr. Anthony Fauci will likely retire by the end of President Joe Biden’s term in January 2025.

Fauci has directed the National Institute of Allergy and Infectious Diseases since 1984. He has also served as Biden’s chief medical adviser since January 2021.

“I have always said that sometime in the reasonable future, I would be stepping down,” Fauci told NBC News. “Thus sometime between now and then I very likely will step down and move on to the next phase in my professional career, whatever that may be.”

However, Fauci said “no decision has been made” about precisely when his retirement will begin — he simply views end of Biden’s term as a marker for his retirement planning.

At age 81, he said, “I do not plan to be in this position forever.”

This is a developing story.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More